Banque Pictet & Cie’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-97,299
| Closed | -$3.1M | – | 377 |
|
|
2024
Q4 | $3.1M | Buy |
97,299
+23,416
| +32% | +$747K | 0.02% | 189 |
|
|
2024
Q3 | $2.13M | Buy |
+73,883
| New | +$2.13M | 0.02% | 184 |
|
|
2023
Q4 | – | Sell |
-102,242
| Closed | -$3.89M | – | 333 |
|
|
2023
Q3 | $3.89M | Sell |
102,242
-4,893
| -5% | -$186K | 0.05% | 163 |
|
|
2023
Q2 | $9.76M | Sell |
107,135
-31,467
| -23% | -$2.87M | 0.09% | 112 |
|
|
2023
Q1 | $9.14M | Sell |
138,602
-20,323
| -13% | -$1.34M | 0.09% | 110 |
|
|
2022
Q4 | $8.22M | Sell |
158,925
-10,046
| -6% | -$519K | 0.09% | 118 |
|
|
2022
Q3 | $11.5M | Sell |
168,971
-10,579
| -6% | -$723K | 0.13% | 92 |
|
|
2022
Q2 | $8.12K | Sell |
179,550
-9,673
| -5% | -$437 | 0.08% | 111 |
|
|
2022
Q1 | $9.61M | Buy |
189,223
+20,734
| +12% | +$1.05M | 0.07% | 122 |
|
|
2021
Q4 | $7.97M | Buy |
168,489
+151,606
| +898% | +$7.17M | 0.06% | 159 |
|
|
2021
Q3 | $556K | Sell |
16,883
-5,742
| -25% | -$189K | 0.01% | 293 |
|
|
2021
Q2 | $1.43M | Buy |
22,625
+1,047
| +5% | +$66.2K | 0.02% | 230 |
|
|
2021
Q1 | $926K | Buy |
+21,578
| New | +$926K | 0.01% | 254 |
|